Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNAM.C. Liu, David R. Spigel, Timothy J. Yeatman et al.|Annals of Oncology|2020Cited by 1.5k
Single-arm, phase 2 study of regorafenib plus nivolumab in patients with mismatch repair-proficient (pMMR)/microsatellite stable (MSS) colorectal cancer (CRC).Marwan Fakih, Andrew Scott Paulson, Kanwal Raghav et al.|Journal of Clinical Oncology|2021Cited by 74
Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutationsJosh Lauring, B H Park, David Cosgrove et al.|Oncogene|2010Cited by 58
Abstract B048: NUC-3373 in combination with irinotecan (NUFIRI) or oxaliplatin (NUFOX) and bevacizumab for second-line treatment of patients with advanced colorectal cancer (NuTide:302)Khurum Khan, T.R. Jeffry Evans, Uma Mukherjee et al.|Molecular Cancer Therapeutics|2023Cited by 1